Enclomiphene: Benefits, Side Effects & How It Works
Enclomiphene: Benefits, Side Effects & How It Works
The content on this page is for general informational and educational purposes only and is not intended as medical advice, a recommendation, or an endorsement of any specific medication, treatment, or health product. Always consult a qualified healthcare provider before making decisions about medications, supplements, or changes to your health regimen. BodySpec does not prescribe, dispense, promote, offer, sell, or facilitate access to any of the pharmaceutical products discussed below.
Testosterone deficiency in men can lead to fatigue, reduced muscle mass, low libido, and mood changes—symptoms of a condition called hypogonadism.
For decades, the standard therapy has been testosterone replacement therapy (TRT). Although effective for raising hormone levels, TRT introduces external testosterone, which can suppress natural production and impair fertility. Enclomiphene is a different class of medication that stimulates the body's own testosterone production through a different mechanism.
Important: Enclomiphene is not FDA-approved. The FDA issued a Complete Response Letter for the branded version (Androxal), and it did not receive market approval. Some healthcare providers prescribe enclomiphene through compounding pharmacies on an off-label basis. Compounded preparations are not FDA-approved, and their safety, effectiveness, and quality are not verified by the FDA before use.
This article provides an evidence-based overview of enclomiphene—how it works, what clinical research shows about its effects, and how it compares with other approaches in published studies.
What Is Enclomiphene?
Enclomiphene citrate is a non-steroidal selective estrogen receptor modulator (SERM). It is one of two isomers found in clomiphene citrate (Clomid):
- Enclomiphene is the trans-isomer that blocks estrogen receptors and stimulates testosterone production.
- Zuclomiphene is the cis-isomer, which is longer-acting, displays mild estrogenic activity, and may contribute to side effects.
Isolating the enclomiphene isomer is intended to reduce the estrogen-like effects attributed to zuclomiphene.
How Does Enclomiphene Work?
The medication acts on the hypothalamic-pituitary-gonadal (HPG) axis:
- The hypothalamus releases gonadotropin-releasing hormone (GnRH).
- GnRH signals the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
- LH stimulates the testes to produce testosterone; FSH supports sperm production.
Estrogen normally provides negative feedback by signaling the pituitary to reduce LH and FSH output. Enclomiphene binds to pituitary estrogen receptors, blocking that feedback signal. The pituitary continues releasing LH and FSH, which in turn elevates endogenous testosterone while maintaining sperm production.
A clinical review in Therapeutic Advances in Urology details this mechanism and notes consistent rises in both LH and FSH during treatment.
What Clinical Research Shows
Testosterone Effects
A phase II trial comparing enclomiphene with transdermal testosterone reported that six weeks of enclomiphene increased mean total testosterone to 604 ng/dL—comparable to testosterone gel—while preserving LH and FSH levels. Dose-response data from the same study showed diminishing returns at higher doses, with the 25 mg group showing only modestly higher testosterone than the 12.5 mg group.
Fertility Preservation
Because LH and FSH remain active, sperm production is maintained during enclomiphene use. A 2023 head-to-head study of enclomiphene vs. clomiphene showed a significant rise in total motile sperm count with enclomiphene.
Side-Effect Profile vs. Clomiphene
By removing the zuclomiphene isomer, enclomiphene may reduce the incidence of mood swings, visual disturbances, and gynecomastia sometimes associated with clomiphene citrate. However, long-term comparative data are limited.
Enclomiphene vs. Clomiphene vs. TRT
| Feature | Enclomiphene | Clomiphene (Clomid) | Testosterone Replacement Therapy |
|---|---|---|---|
| Mechanism | Blocks pituitary estrogen receptors; stimulates LH/FSH | Mixed estrogen agonist/antagonist | Provides exogenous testosterone |
| Testosterone source | Endogenous (body produces its own) | Endogenous (body produces its own) | Exogenous (external hormone) |
| Fertility impact | Sperm counts maintained in studies | Often maintains sperm, less targeted | Typically suppresses spermatogenesis |
| LH/FSH levels | Increase | Increase | Suppressed |
| Reported side effects | Mild headache, GI discomfort | Mood swings, visual changes | Testicular atrophy, hematocrit elevation |
| Route | Oral tablet | Oral tablet | Injections, gels, pellets |
| FDA status | Not approved | Approved for female ovulation induction; off-label for men | Multiple approved formulations for male hypogonadism |
Clinical Contexts Discussed in the Literature
Published research has examined enclomiphene primarily in the following contexts:
- Secondary hypogonadism — men with low testosterone due to impaired hypothalamic-pituitary signaling rather than primary testicular failure (Rodriguez et al. 2016)
- Fertility preservation — men who need testosterone support but want to maintain spermatogenesis
- Alternative to exogenous testosterone — patients and providers seeking an oral option that preserves endogenous production
Whether enclomiphene is appropriate for a given individual is a clinical decision made by a qualified healthcare provider based on laboratory findings, symptoms, medical history, and treatment goals.
Potential Side Effects & Safety
Reported side effects in published studies are generally mild and include headache, nausea, and digestive discomfort. Some men experience transient increases in estradiol.
Visual disturbances (blurred vision, halos) are documented with clomiphene citrate — which contains enclomiphene as its active isomer — so clinicians monitor for these as a precaution, though direct enclomiphene data on this are limited.
Long-term safety data are limited. Published trials have examined durations of 6–26 weeks. The long-term effects of extended use are not well characterized in the literature. Enclomiphene is banned by WADA under the SERM classification; tested athletes should be aware that use constitutes a doping violation.
Frequently Asked Questions
How quickly do testosterone changes appear in studies?
Blood tests in published trials typically showed rising testosterone within 2–4 weeks of treatment initiation.
How is enclomiphene obtained?
Because enclomiphene is not FDA-approved, it is prepared by compounding pharmacies when prescribed by a healthcare provider. It is not available at standard retail pharmacies.
Can women use enclomiphene?
Enclomiphene is not typically used for women. The FDA-approved therapy for female ovulatory dysfunction is its parent compound, clomiphene citrate, which contains both the enclomiphene and zuclomiphene isomers.
Is enclomiphene FDA-approved?
No. The FDA issued a Complete Response Letter for the branded version (Androxal), and it did not receive market approval. Current access is through compounding pharmacies, which are not subject to the same regulatory oversight as FDA-approved medications.
The BodySpec Take
Enclomiphene is a non-FDA-approved SERM that has shown testosterone-raising effects while preserving fertility markers in published clinical studies. Because it is not FDA-approved and long-term data are limited, all decisions about enclomiphene should be made with a qualified healthcare provider who can evaluate individual medical needs and monitor appropriately.
Regardless of what approach you and your healthcare provider choose, objective body composition data can help you understand what's changing over time. A DEXA scan measures fat mass, lean mass, visceral fat, and bone density—providing context that a scale alone cannot.
Book a BodySpec DEXA scan to track changes in lean mass, fat mass, and visceral fat.
Educational content only; not medical or legal advice. BodySpec does not diagnose, treat, prescribe, or sell medications.
